SIRT5 and cancer: SIRT5 inhibitors (sirtuin-inhibiting compounds, STICs) have been studied for their potential role in the treatment of metabolic disorders [6,40], neurodegenerative pathologies [23,41,42], cardiovascular diseases [42,43], and cancer [3,44].